Human papillomavirus vaccinations' impact on preterm birth rates.

Removal of human papillomavirus (HPV) infection associated precancerous cervical lesions by conization is one of the most important causes of preterm birth. Prophylactic HPV-vaccinations can prevent these lesions and reduce the need of their ablative treatment, thereby preventing preterm births. We...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Public Health Vol. 36; no. 1; pp. 214 - 220
Autores principales: Koivisto, Tiina, Kalliala, Ilkka, Eriksson, Tiina, Nieminen, Pekka, Lehtinen, Matti, Louvanto, Karolina
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA Feb2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191655783&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 191655783
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11011262
        BHW
      jtl: European Journal of Public Health
      issn: 11011262
      maglogo: N
    pubinfo:
      dt: Feb2026
      vid: 36
      iid: 1
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        191655783
        191655783
        191655783
        10.1093/eurpub/ckaf185
        191655783
      ppf: 214
      ppct: 6
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Human papillomavirus vaccinations' impact on preterm birth rates.
      aug:
        au:
          Koivisto, Tiina
          Kalliala, Ilkka
          Eriksson, Tiina
          Nieminen, Pekka
          Lehtinen, Matti
          Louvanto, Karolina
        affil: Faculty of Medicine and Health Technology, Tampere University, Tampere, FinlandDepartment of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland
      sug:
        subj:
          Papillomavirus Infections Prevention and Control
          Papillomavirus Vaccine
          Childbirth, Premature Evaluation
          Women
          Pregnancy Complications, Infectious Prevention and Control
          Human
          Human Papillomavirus Viruses
          Community Health Services
          Finland
          Prospective Studies
          Gestational Age
          Logistic Regression
          Primiparas
          Odds Ratio
          Descriptive Statistics
          Confidence Intervals
          Morbidity
          Data Analysis Software
          Female
          Male
          Chi Square Test
          Funding Source
          Pregnancy
          Random Assignment
          Female
          Male
      ab: Removal of human papillomavirus (HPV) infection associated precancerous cervical lesions by conization is one of the most important causes of preterm birth. Prophylactic HPV-vaccinations can prevent these lesions and reduce the need of their ablative treatment, thereby preventing preterm births. We evaluated whether preterm birth rates vary between HPV-vaccinated and unvaccinated women. Study subjects comprised 6200 cluster-randomized cohorts of HPV-vaccinated and 1667 hepatitis B-virus vaccinated women born in 1992–1993, and age- and community-aligned reference cohort of 19 473 unvaccinated women born in 1990–1991. Age-aligned registry linkage data from the nationwide Finnish Medical Birth Registry were retrieved up to 2018 (older age cohorts) and 2020 (younger age cohorts). Preterm births were categorized as early (gestational age of 22 + 0–33 + 6 weeks) and late preterm births (gestational age 34 + 0–36 + 6 weeks). Logistic regression was used to evaluate the association of HPV-vaccination and preterm births. By the age 28, 23.9% (n  = 1484) of HPV-vaccinees and 28.4% (n  = 6006) of the unvaccinated women had at least one childbirth recorded. Precisely, 4.1% (n  = 61) of HPV-vaccinated and 5.2% (n  = 310) of unvaccinated primiparas had a preterm birth. The association of preterm birth with HPV-vaccination was protective with a borderline significant odds ratio of 0.79 (95% CI 0.59–1.04). Most preterm births were at late preterm among both HPV-vaccinees (3.1%) and unvaccinated women (3.4%). Prophylactic HPV-vaccination is likely to reduce the incidence of preterm births. The decrease of preterm births is crucial to reduce the need for extensive and costly postnatal care and life-long morbidity.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N